Recognition highlights MadeAi’s use of AI to accelerate evidence generation while maintaining the scientific rigor, traceability, and human oversight required in life sciences Cambridge, MA—September 10, 2026—MadeAi, the AI-enabled evidence synthesis provider for life sciences, today announced that it has been named the winner of the 2026 Fierce AI Innovation Award for AI Innovation in…

Newest version of MadeAi™ hailed by judges as “an impressive application of governed AI to a complex and highly regulated life-sciences workflow”  Cambridge, MA, August 19, 2026—MadeAi™, a purpose-built AI platform for evidence synthesis in regulated life sciences, announced that its updated platform was a winner of a Gold Stevie® Award in The 23rd Annual…

Achievement recognizes organizations, products, teams, and individuals delivering measurable results through artificial intelligence CAMBRIDGE, April 9, 2026—MadeAi, Inc. (MadeAi) today announced it has been named a winner in the 2026 Artificial Intelligence Excellence Awards, in the Generative AI category supporting life sciences. Presented by the Business Intelligence Group, the award recognizes organizations, products, teams, and…

GLASGOW, SCOTLAND and CAMBRIDGE, MA, USA, November 10, 2025—At ISPOR Europe 2025 today, MadeAi™, the GenAI-powered evidence synthesis and report generation platform for life sciences, announced the launch of new capabilities designed to streamline and accelerate global value dossier (GVD) and Joint Clinical Assessment (JCA) submissions. With these advancements, MadeAi delivers the most comprehensive, AI-native…

Newest version of MadeAi™ for content synthesis hailed by judges as “a significant leap in applying Generative AI to the life sciences”   Cambridge, MA, August 25, 2025—CapeStart, an AI solutions and services firm, announced that its CapeStart MadeAi™ GenAI Platform for Life Sciences Content Synthesis was a winner of a Stevie® Award in The…